title: Case of NOD2-Associated Autoinflammatory Disease Successfully Treated With Sulfasalazine.
authors.affiliation: Division of Allergy, Clinical Immunology, and Rheumatology Department of Medicine, University of Kansas Medical Center, Kansas City, KS mayaestephan@icloud.com Division of Rheumatology, Allergy, and Immunology, Stony Brook University, Stony Brook, NY Division of Allergy, Clinical Immunology, and Rheumatology Department of Medicine, University of Kansas Medical Center, Kansas City, KS.
authors.forename: Maya
authors.initials: M
authors.lastname: Estephan
authors.forename: Qingping
authors.initials: Q
authors.lastname: Yao
authors.forename: Jason
authors.initials: J
authors.lastname: Springer
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D056660:Hereditary Autoinflammatory Diseases / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008297:Male; D053473:Nod2 Signaling Adaptor Protein / Q000235:genetics*; D012698:Serologic Tests / Q000379:methods; D012460:Sulfasalazine / Q000008:administration & dosage*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein; D012460:Sulfasalazine